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ABSTRACT 
 
 
Throughout history wounds have been a cause of great distress to the sufferer and a 
major burden to society. Especially the slow-healing wounds have been an issue and in 
order  to  find  healing  treatments,  complementary  methods  have  been  developed. 
Negative pressure wound therapy (NPWT) is one such complementary method. The 
overall aim of this thesis was to study if NPWT is an effective and safe method for 
wound treatment and to enhance the knowledge of the patients’ experience of the 
treatment and the impact on his/her health-related quality of life (HRQoL). 
 
Studies  I and  II  aim at describing basic demographic  data, co-morbidity,  treatment 
results and complications in relation to wound etiology in patients treated with NPWT 
and at identifying risk factors for non-successful treatment and complications. A chart 
review was conducted based on a consecutive series of 87 patients treated with NPWT. 
Successful treatment was noted for 62 patients (71%). Treatment complications were 
observed in 18 patients (21%). The strongest risk factors associated with non-successful 
treatment  were  having  a  pressure  ulcers  or  a  positive  culture  for  Staphylococcus 
Aureus, and for complications a positive culture for either Staphylococcus Aureus or 
Pseudomonas Aeruginosa. Patients with insufficient peripheral circulation in the lower 
extremities had a risk of both non-successful treatment and complications. 
 
Study  III  is a descriptive  qualitative  study aiming  at describing  the experience  of 
patients with wounds treated with advanced moist wound therapy (AMWT) or with 
NPWT. Data were collected from 15 day to day diaries written by patients during their 
treatment and analysed with content analysis. The results identified an overall theme 
“threat to normality” and three categories “impact on daily life”, “manageability” and 
“powerlessness”. For patients treated with AMWT, the main concern was pain, while 
patients treated with NPWT focused on the machine and its optimal functioning. 
 
Study   IV  is  a  translation  and  validation  study  of  the  wound-specific   HRQoL 
instrument Cardiff Wound Impact Schedule (CWIS), motivated by a requirement of 
extended  tools  for  evaluating  HRQoL,  generated  by Studies  I-III.   A total  of  117 
patients with acute and hard-to-heal wounds were included. The assessment of the 
psychometric properties of the instrument as to reliability, validity, responsiveness and 
ceiling- and floor-effect proved the Swedish version of the CWIS to be a reliable and 
valid tool for measuring HRQoL. 
 
Conclusions 
NPWT may be an effective and safe treatment method where the outcome is dependent 
on the etiology of the wound. The risk factors identified of a non-successful result 
pinpoint the necessity of taking steps to ensure meticulous controls of infection and 
insufficient peripheral circulation. The NPWT has an impact on the patients´ HRQoL. 
Patients undergoing wound treatment have different focus, concerns and needs related 
to treatment modality. Further research on effectiveness of the treatment and impact on 
the patient’s HRQoL is required and the Swedish version of the CWIS has been proven 
useful for the assessment. 
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1  INTRODUCTION 
 
 
What is a wound? Cat's scratch on a finger or an ulcer that covers the entire lower 
limb? Whatever cause, it is not the size or location that plays a role for the person 
involved, other more complex factors decide whether the wound is something that heals 
in a couple of days or will become a long lasting problem. Throughout history, wounds 
have been a cause of great distress to the sufferer and a major burden to society. 
Especially the slow-healing wounds have been an issue, and in order to find healing 
treatments, complementary methods have been developed. Negative Pressure Wound 
Therapy  (NPWT)  is one  such  complementary  method.  Even  if studied  in multiple 
studies the effects of the treatment and the impact on the patient's health-related quality 
of life (HRQoL) still need to be explored. 
 
Medical  science  contains  a  wide  range  of  aspects  of  the  medical  field,  including 
nursing,  physiotherapy  and occupational  therapy.  Wound  treatment  is complex  and 
need a multi-dimensional  approach using different facets within the medical science. 
From one perspective it is important to establish knowledge on treatment efficacy and 
safety, i.e. whom to treat with NPWT and whom not to treat. From another perspective 
it is essential to get a deeper understanding  of the impact the treatment  has on the 
patient's HRQoL and everyday life, and how the patient experiences the treatment. It is 
also important to identify similarities and differences in experience between patients 
treated with NPWT and those treated with traditional  wound treatments,  giving the 
health care professionals possibilities to provide an optimal and individualized wound 
care. 
 
This thesis encompasses different perspectives of the medical science, including the 
patient's perspective, to highlight various aspects of the concept NPWT. 
2  
 
 
 
 
 
 
 
2  BACKGROUND 
 
 
2.1   WOUNDS AND WOUND HEALING 
 
A wound is defined as an injury creating a disruption in the normal anatomical structure 
and function of the skin. There are two different types of wounds: vulnus that is an 
acute wound, which heals according to the normal wound healing process, and ulcus 
that is defined as hard-to-heal wounds (previously labeled chronic wounds) such as leg 
ulcers, pressure ulcers and diabetic foot ulcer. These wounds have a duration of more 
than six weeks and often show a disturbed wound healing process due to underlying 
causes other than direct trauma1. 
 
Wound healing is a complex process in which the skin repairs itself after injury. In the 
normal skin, the epidermis and dermis forms a protective barrier against the external 
environment, but once the protective barrier is broken, the normal process of wound 
healing is immediately set in action
1
. 
 
The classic model of normal wound healing is divided into three sequential, yet 
overlapping,   phases:   inflammatory,   proliferative   and  remodeling.   However,   this 
process can easily be interrupted due to several inhibiting factors such as smoking, 
ischemia in the tissue, diabetes and infections, leading to the formation of a hard-to- 
heal wound, by definition wounds that have failed to heal within six weeks
1-4
. 
 
Wounds may heal by three principles: primary, secondary or tertiary healing. Primary 
healing occurs when the wound edges are put together, often with sutures, and healing 
occurs with minimal tissue defects. Secondary healing occurs in open wounds, when 
the wound edges are not put together and healing occurs with formation of granulation 
tissue. Tertiary healing is delayed primary healing and occurs when a wound is allowed 
to heal openly for a few days and then is closed with secondary sutures as if primarily5. 
 
 
2.2   WOUND TREATMENTS 
 
2.2.1   Advanced Moist  Wound  Therapy 
 
The modern theories of moist wound therapy for wound treatment were developed in 
the 1950's when Odland showed that wound healing in unbroken blisters was faster 
than in broken blisters, indicating that occlusive moist environment  was beneficial6. 
These results were followed up by the research by Winter published in 1962 which 
made him considered “the father of moist wound healing”. He investigated the effect of 
occlusive dressings compared to air drying for epithelialization in wounds, with a large 
difference in favour for occlusive dressings
7
. Moist wound therapy can be attained by 
using wet gauze. This method, however, demands continuous dressing changes to keep 
the gauze wet and the wound moist, and a large amount of nursing resources. A review 
article by Eaglstein concludes the existing research in a general consensus for wound 
treatment with recommendations of advanced occlusive dressings for creating a moist 
environment in the wound
8
. This method is called Advanced Moist Wound Therapy 
(AMWT). Today there are numerous commercial types of AMWT-dressings available, 
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such as hydrofibre, hydrocolloids, films, foams, hydrogels and alginates. This wide 
selection of dressing categories enables the health-care personnel to decide on the most 
appropriate  treatment  for  the  individual  patients,  given  the  characteristics  of  the 
wound
9
. 
 
Despite  solid  evidence,  there  still  exist  a  skepticism  and  resistance  towards  using 
occlusive dressings in the clinical setting, mainly based on the fear of infections
8
. 
Paradoxically,   as  there   is  evidence   of  fewer   infections   when   using   occlusive 
dressings
10
. Eaglstein discusses this skepticism in his review article and defines it as 
being  a  medical  conservatism  to  acceptance  of  new  medical  discoveries  and  a 
predilection  of  favoring  more  glamorous  and  high-tech  innovations,  leading  to  a 
selective interpretation of the evidence
8
. 
 
2.2.2   Negative  Pressure Wound  Therapy 
 
History 
NPWT  originates  from  cupping  therapy,  which  is  an  ancient  form  of  alternative 
medicine in which a local suction is created on the skin which mobilizes the blood flow 
in order to promote  healing.  The earliest record  of cupping is from ancient Egypt, 
China and The Middle East
11
. 
 
In the 1830's the so called Junod's boot was developed by Dr. Junod. It was known as 
the haemospasic apparatus or exhausting apparatus (Figure 1). The idea was similar to 
cupping but on a larger scale. By sucking the blood into the limb and withdrawing it 
from the general circulation, it was believed to reduce fever and forestall inflammatory 
conditions
12
. 
 
 
Figure 1. Junod's exhausting apparatus
13
. Used with permission from The Lancet. 
 
 
In 1986-1987 the five so called “Kremlin papers” described closed suction as effective 
in decreasing wound healing time and reducing hospitalization as well as reducing 
bacterial counts in purulent wounds, using a method of wall suction and gauze to create a 
negative pressure to evacuate exudates from post operative wounds
14
. 
 
In the late 1980's, Chariker, Jeter, Tintle and Bottsford used negative pressure with the 
gauze-technique in seven patients with fistulas. The result was minimized morbidity, 
improved  wound contracture  and re-epithelialization,  and reduced nursing resources 
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and costs15   The first commercially NPWT system was available on the market in 1995. 
It was the Vacuum Assisted Closure® (VAC) introduced by the American researchers 
Argenta and Morykwas. They used poly-urethane foam as wound filler instead of the 
previous gauze-technique, with excellent result: 99% of 300 patients with acute, sub- 
acute and hard-to-heal wounds responded favorably to the treatment16 
 
Today numerous medical manufacturers provide NPWT systems, both with the gauze- 
technique and the foam-technique, and there is an ongoing excessive development of 
new products and also improvements of existing systems. 
 
Treatment 
The NPWT method consists of a device that creates a vacuum in the wound using a 
wound filler of polyurethane foam, polyvinyl alcohol foam dressing or gauze (Figure 
2). The foam, or gauze, is adapted exactly after the size of the wound (a) and then the 
wound filler and the entire wound are covered with a transparent adhesive drape (b). A 
hole is cut in the drape and a suction tube is adapted (c). The tube is connected to the 
vacuum machine and a subatmospheric pressure ofnormally  80-125 mmHg is applied 
(d), dependent on which system used. 
 
 
 
 
            d 
 
Figure 2. Dressing technique.  Used with permission from KCI International. 
 
 
Indications and goals of treatment with NPWT 
NPWT can be used in wound treatment for a broad variety of indications, both for 
acute wounds and for hard-to-heal wounds. For some diagnoses the treatment has 
become the gold standard and is routinely used, for others the indication has been more 
controversial. An overview of the indications is presented in Table I. The treatment 
goals ofNPWT are mainly for secondary healing: to prepare the wound for secondary 
intention such as split-thickness skin graft, secondary surgical suture or continuous 
treatment with different dressings. However, using NPWT as a tool for managing the 
wound also exists, i.e. to reduce complexity and size, to manage wound fluid and to 
prevent deterioration of the wound. Treatment goal in terms of improvement of the 
patients' HRQoL is discussed and controversial but can be seen as part of achieving a 
comfortable and functional dressing solution17 
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Table I. Indications and advantages with NPWT in the literature 
 
 
Indications and advantages Ref 
Acute/traumatic wounds  Facilitates surgical closure 
18-20
 
Prepares for continued treatment with AMWT-dressings 
Shifts down the reconstructive ladder with fewer and less 
complex surgical interventions 
- Open abdominal wounds Gold standard in care 
21-23 
- Dehisced sternal wounds Gold standard in care 
24-26
 
following cardiac surgery Reduces mortality and morbidity 
- Split-thickness skin graft Gold standard with highest level of evidence 
27-32
 
Improves graft success 
- Fasciotomy  Higher rate of primary closure 
33,34
 
Time to primary closure or skin graft is shorter 
Hard-to-heal wounds 
- Diabetic foot ulcers Shorter time to heal 
35-40
 
Lower amputation rates and costs 
- Venous leg ulcers Accelerates wound bed preparation 
32,41,42
 
Effective in non-respondence to compression therapy 
- Pressure ulcers Useful for pressure ulcers of categories 3 and 4 
17 
HRQoL  Reduction of general wound pain 
43-45
 
Reduction of odour 
Control of exudates 
 
 
Contraindications and complications with treatment 
In the manufacturer's manual, the contraindications are listed being untreated 
osteomyelitis, non-enteric or unexplored fistulae, present necrotic tissue, malignant 
wounds and direct placement over exposed structures e.g. tendons, ligaments, blood 
vessels, anastomosis sites, organs and nerves. Precautions should be taken for patients 
with active bleeding, with difficult wound haemostasis and patients under anticoagulant 
therapy
46
. Bearing the contraindications in mind it is a bit surprising that research is 
presented where clearly these contraindications have not been followed. For example: 
complications  in  terms  of  bleeding  causing  severe  injuries  and  death  have  been 
described, mainly associated with vascular grafts, sternal and groin wounds and 
anticoagulant  therapy
47
. In Sweden a case series has been published describing five 
cases of severe bleeding due to rupture of the right ventricle when deep sternal wound 
infection was treated with NPWT, three with fatal outcome
48
. 
 
Complications and adverse events associated with NPWT have not been thoroughly 
investigated, but reports of complications are present in the literature
47,49
. Veurstaek et 
al showed statistically significant higher presence of cutaneous damage secondary to 
therapy, and a numeric thus not statistically significantly higher complication rate in the 
NPWT group (40%) compared to treatment with AMWT (23%)
32
. 
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Decrease in pain has been regarded as an advantage when using NPWT for wound 
treatment. However, the review by Ousey, Cook and Milne revealed that pain was the 
most  frequently  cited  reason  for terminating  the NPWT.  Pain  was reported  during 
dressing changes and the pain rating was higher in the group using foam as wound filler 
compared to gauze, which may be due to adhesion and tissue in-growth caused by the 
effect of the foam
50
. 
 
Limitations of mobility and a deterioration of the physical functioning was a major 
HRQoL complication seen in 42% of the patients in the study by Mendonca, Drew, 
Harding and Price
51
. This negative effect of NPWT was also described by patients in 
the studies of Abbots and of Bolas and Holloway
52,53
. 
 
 
2.3   RESEARCH METHODS AND OUTCOME MEASURES 
 
Research can be divided into two basic categories or paradigms, quantitative and 
qualitative research
54
. An overview of the properties of the two research approaches is 
presented in Table II. 
 
Table II. Overview of the properties of quantitative and qualitative research
54
 
 
Quantitative research Qualitative research 
To quantify data and generalize results To gain an understanding of underlying 
Objective / from a sample to the population of reasons and motivations. 
purpose interest. To uncover prevalent trends in thought 
To measure the incidence of various and opinion. 
views and opinions in a chosen sample. To provide insights into the setting of a 
Sometimes followed by qualitative problem, generating ideas and/or 
research which is used to explore some hypotheses for later quantitative 
findings further. research. 
Sample  Usually a large number of cases Usually a small number of non- 
representing the population of interest. representative cases. Respondents 
Randomly selected respondents.  selected purposively. 
Data  Structured techniques such as Unstructured or semi-structured 
questionnaires or equipment to collect techniques e.g. interviews or diaries. 
collection  numerical data. 
Data analysis      Statistical. Non-statistical. 
Findings are conclusive and usually 
descriptive in nature. 
Outcome  Used to recommend a final course of Exploratory and/or investigative. 
action for the population of interest. Findings are not conclusive and cannot 
be used to make generalizations about 
the population of interest. 
Researcher Researcher tends to remain objective. Researcher tends to become 
subjectively immersed in the subject 
matter. 
 
Quantitative  methods have a focus on numbers  and frequency,  provide information 
easy to analyse statistically. They are associated with a scientific and experimental 
approach  but  are  criticized  for  not  providing  an  in-depth  description.  Qualitative 
methods on the other hand are ways of collecting data which are concerned with 
describing meaning rather than drawing statistical conclusions and so provide a more 
in-depth and rich description
54
. 
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The  so  called  "qualitative-quantitative  debate",  arguing  which  method  is  the  most 
accurate and reliable has been going on for decades. However, in modern research, a 
combination of qualitative and quantitative approach is recommended, which allows for 
statistically reliable information obtained from numerical measurements to be backed 
up and enriched by information on the participants' explanations and experience
55
. 
 
A large amount of clinical epidemiological methods and study designs exist for 
quantitative research. Nevertheless there is a lack of high quality evidence in wound 
research, since many studies are based on insufficient sample size, short follow-up time 
and issues concerning comparability between different studies due to poor description 
of the control group. Often the treatment in the control group is described as "standard 
of care" which could mean anything from saline gauze dressings to AMWT
56
. 
 
The impact of the wound and the wound treatment can be deeper understood by 
conducting qualitative research. This gives an opportunity to explore the patients' 
perceptions  and experience  of having a wound and undergoing  a wound treatment. 
There are several designs used in qualitative wound research, and different methods are 
available  for  collecting  data.  Questionnaires  and  interviews  are  the  most  common 
methods for data collection in qualitative research
54
. The shortcomings of these two 
traditional qualitative methods are that the patients are asked to recall past experience, 
something  that  has  been  shown  to  be  unreliable  by  causing  recall  bias
57,58
.  This 
systematic bias occurs when answering questions that are affected by the memory and 
is considered as the most significant methodological factor affecting self-reported data. 
To avoid  and  minimize  the effect  of recall  bias,  a number  of methods  have  been 
developed to bring the assessment closer to real-time. Using diaries to collect data is 
one method
59
. Written diaries were initially used in the 1940's as a way of collecting 
health data from patients. In the beginning diaries were seen as a tool for the patients to 
remember  health events, but over time they became a way to reduce recall bias in 
research. The methodological limitations with diaries are the risk of poor data quality 
and   non-compliance   by   patients   which   can   decrease   reliability
59,60
.   Broderick, 
Schwartz, Shiffman, Hufford and Stone showed that auditory signaling enhances 
compliance with the patients' use of diaries
61
. 
 
2.3.1   Wound-related outcomes 
 
The most common endpoints used in wound research are time to complete healing and 
percentage of wound size change during the study period. A weakness of the two 
endpoints is the subjective interpretation of when a wound is completely healed, how to 
measure  the wound  and what method  to use for measuring  wound  size56.  Another 
problem with these endpoints is that the intervention or treatment often is performed for 
reasons  other than complete  healing,  as in the case of NPWT.  To achieve  a more 
clinical and realistic outcome measure, the endpoints should instead be related to the 
purpose of the intervention. Examples of endpoints could be preparation of wound bed 
for secondary intervention, control of exudation, wound debridement, reduction of pain, 
rate of granulation, dressing performance etc as recommended by European Wound 
Management Association (EWMA)56. The review articles published so far by Cochrane 
Library, internationally  recognized as the highest standard in evidence-based  health- 
care  and  often  leading  the  research  opinion,  and  the  Swedish  Council  on  Health 
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Technology  Assessment,   called  SBU,  indicative  in  Swedish  healthcare,   all  use 
complete healing as primary outcome measure. 
 
In future research the question to address must be what outcome to use. The most 
sensible  and logical  answer  would  be to use an outcome  that reflects  whether  the 
intention of the treatment has been achieved or not. 
 
2.3.2   HRQoL-related outcomes 
 
The concept HRQoL is defined as those aspects of overall quality of life that can be 
clearly shown to affect health, either physical or mental
62
. 
 
HRQoL can be measured by two basic approaches: generic instruments that provide a 
summary of HRQoL in general terms, and disease- or condition-specific  instruments 
that are adapted to different diseases or conditions. The generic instruments are used to 
compare  different  diseases  and  conditions  in  a  wider  sense,  while  the  specific 
instruments  can detect  small but clinically  relevant  differences  and can be used to 
measure the impact the disease has on the individual. Disease-specific tools often have 
advantages  over  the  generic  regarding  ease  of  administration,  acceptability  by  the 
patient, cost, and simplicity of scoring. It is recommended to combine the two for 
complete assessment of the patient's HrQoL63. 
 
Examples of commonly used generic HRQoL-instruments  in health research are the 
SF-36, the EQ-5D and the Nottingham Health Profile (NHP). The SF-36 (Short Form- 
36  Health  Survey)  contains  36  items  which  measure  eight  health-related  domains: 
physical activity, role-physical, body pain, general health perceptions, vitality, social 
functioning, role-emotional, and mental health. The 36 scores are summerized and 
transformed into a scale from zero (poor health) to 100 (good health). The SF-36 has 
good  to  excellent  psychometric  properties  of  reliability  and  validity  and  appears 
sensitive to change64. The EQ-5D (EuroQoL) consists of five items each measuring one 
health domain: mobility, self-care, role (or main) activity, family and leisure activities, 
and pain and mood. The respondents also rate their health on a visual analogue scale 
from zero (worst imaginable health state) to 100 (best imaginable health state) 
65
.  The 
NHP consists of two parts which can be used together or separately. Part I consists of 
38 items dealing with six domains of health: energy levels, pain, emotional reaction, 
sleep,  social  isolation  and  physical  abilities.  Each  question  is assigned  a weighted 
value, and the sum of all weighted values of a given domain adds up to 100. Part II 
contains seven general questions regarding daily life
66
. 
 
Having a wound and the necessity of having to undergo wound treatment affects the 
patient's daily life and has an impact on the HRQoL. This was first acknowledged by 
Lindholm, Bjellerup, Christensen and Zederfeldt. They studied how leg ulcers affected 
the patient's HRQoL using the NHP, and found that the wound had a clearly negative 
impact on the patient's perceived health, particularly evident for the male patients in 
comparison  to  the  norm  population.  Pain  was  the  most  bothersome  symptom  and 
created the most stress67. 
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Following Lindholm et al's pioneering study
67
, a large amount of research has been 
conducted regarding the impact of HRQoL in wound patients, indicating that patients 
with wounds have a significantly  poorer HRQoL compared  to healthy people. In a 
review article by Persoon et al which included results from both qualitative and 
quantitative research, pain was recognized as the major concern in studies of both 
designs
68
. Other limitations and restrictions of the daily life has been described in the 
literature as due to immobility, worries, frustrations and being dependent on others
68-70
. 
 
The advantages of using instruments like SF-36, EQ-5D and NHP are that they are well 
validated, frequently used empirically and give the possibility to compare results across 
different diseases, conditions, populations, or studies
62
. To satisfy the requirement of a 
disease-specific  tool  for  evaluation  of  the  HRQoL  of  wound  patients,  the  Cardiff 
Wound Impact Schedule (CWIS) has been developed at Cardiff University of Wales 
College of Medicine. The CWIS is validated to measure the HRQoL of patients with 
hard-to-heal wounds such as venous leg ulcers and diabetic foot ulcers, but has also 
been  used  for  patients  with  acute  wounds
51,71-73
.  The  instrument  consists  of  47 
questions which are divided into three domains, 'well-being' (WB), 'physical symptoms 
and daily living' (PSDL) and 'social life' (SL). The values of the items add together and 
calculate according to a specific formula that creates an index from zero to 100, where 
a high value represents a high HRQoL and a low value a low HRQoL. Validation of the 
CWIS was made with the SF-36 as gold standard. CWIS is translated and validated to 
French, German and American English languages but not to Swedish
74
. 
 
 
2.4   RESULTS OF PREVIOUS RESEARCH IN NPWT 
 
NPTW has been in clinical use since 1995. A literature search of Medline revealed over 
1400 published articles. As presented before, a lot of the articles can be disputed as 
using unrealistic outcome variables or being poor in study design. The publications up 
to today conclude that sufficient evidence for the superior clinical use of NPWT is 
presented only for split-thickness grafts27-32. Research showing positive results of the 
efficiency of NPWT exists but with weaker levels of evidence, not leading to other 
conclusions than indications of possible use, presented in Table II. 
 
Examples of the interpretations of the existing research are three Cochrane reviews 
evaluating NPWT in the area of hard-to-heal wounds (chronic), partial-thickness burns 
and skin grafts, and surgical wounds healing by primary healing which conclude that 
there  is  not  sufficient   evidence  that  NPWT  is  superior  to  AMWT  and  other 
conventional  wound treatment  methods  and that additional  studies  are required75-77. 
The SBU-report from the Swedish Council on Health Technology Assessment also 
presents a review of the published research on NPWT. The final conclusion is that the 
advantage of NPWT is unclear in many clinical situations and that there is a major lack 
of existing high quality studies to clearly evaluate the treatment. The SBU-report also 
goes as far as asking whether it is ethically justifiable to use the method at all since it 
has not been proven to be superior to conventional wound healing
31
. However, bearing 
in mind that these reviews solely evaluated randomized controlled trials (RCT's) with 
complete healing as the primary endpoint, the question is if these results should be 
interpreted with precaution. 
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Another example is the review article by Xie, McGregor and Dendukuri on diabetes 
foot ulcers where the evidence for beneficial use of NPWT has been regarded as 
consistent and given as an example where NPTW can be used
40
. However, the studies 
assessed relate to patients with sufficient arterial circulation in the lower extremities, 
something that is mentioned in passing in the review, giving a situation where the 
interpreter could believe that diabetic wounds could be treated with NPWT as such. 
Instead the clinical recommendations  are that NPWT should not be used in patients 
with insufficient circulation and only be used in a chronic ischemic limb when all other 
treatment alternatives have failed, and finally never in an acute ischemic limb
17
. 
 
The use of NPWT in pressure ulcers has also been debated, and the literature shows 
varying results. The general opinion is that NPWT has not been proven to be more 
effective  than  other  control  interventions  and  the  clinical  recommendation  is  that 
NPWT is suitable only for pressure ulcers in the most severe stages (categories 3 and 
4), but even then a possible use could be not to heal the wound but to improve the 
patient's   HRQoL   with   fewer   dressing   changes   and   a   better   comfort   of   the 
dressing17,78,79. 
 
The World Union of Wound Healing Societies' (WUWHS) consensus document for 
NPWT states that NPWT can have a positive impact on a patient's HRQoL
80
. However, 
Ousey et al conclude in their review of the impact of NPWT on the patient's HRQoL 
that it is not possible to determine whether the impact is positive, neutral or negative, 
based on existing research
50
. 
 
One small cohort study by Mendonca et al using the CWIS as instrument for measuring 
HRQoL at treatment start and at four weeks after treatment did not find any differences 
in  patients  with  acute  or  hard-to-heal  wounds.  The  study  showed,  however,  that 
treatment with NPWT may worsen the HRQoL for some patients. Particularly the 
physical-functioning domain in ambulatory patients was affected during this period of 
time51. In another study using the CWIS to compare HRQoL in patients treated with 
either NPWT or standard wound treatment, the results showed no overall significant 
differences  between  the  two  treatments.  However,  an  unexpected  improvement  of 
HRQoL in the domain social life was identified in the group treated with NPWT, which 
the authors explained could be due to the small sample size or to enhanced attention 
given to patients treated with a machine
81
. Why it was interpreted as unexpected is a 
little surprising as one question that comes to mind is that NPWT often reduces the 
odour from the wound which could lead to a wish to retain a social life. 
 
An improved  HRQoL during NPWT in patients  with hard-to-heal  wounds has also 
been reported. Vuerstaek et al showed a similar improvement in patients' HRQoL and 
decrease in pain scores in patients treated with NPWT. However, in the control group 
with patients treated with AMWT the changes  were significantly  faster than in the 
NPWT group32. 
 
The impact on the HRQoL during NPWT has been explored qualitatively  in a few 
studies  focusing  on the patient's  conceptions  and experience  of the treatment.  Both 
studies  by  Abbotts  and  by  Wallin  showed  that  the  treatment  with  NPWT  was 
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experienced as stressful, especially regarding the impact on daily life and organization 
around dressing changes
52,82
. An interview study by Bolas and Holloway confirms the 
findings in the two latter studies but also emphasizes the technical aspect of NPWT and 
describes the  feelings of distress associated with its use
53
. 
 
Since the literature presents varying results with both negative and positive impact on 
the patient's HRQoL, it is necessary to perform larger quantitative studies and also to 
conduct more qualitative research on the effects of NPWT on the HRQoL of patients 
with different  wound  etiology.  Upton,  Stephens  and Andrew  recently published  an 
article reviewing the research on patients' experience of treatment with NPWT. They 
also emphasize the need of more knowledge, particularly exploring the patient's 
experience throughout the treatment process in order to minimize negative effects of 
NPWT83. 
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3  THESIS RATIONALE 
 
 
Although numerous studies on treatment with negative pressure have been conducted 
there is still a lack of evidence of which patients and which wound types will have the 
best result of the treatment. 
 
In the clinical use, NPWT has sometimes been viewed as a “simple dressing” which 
could be considered as an ignorance of the risks and safety issues with the treatment. 
This phenomenon is also seen in research, where adverse events and risk factors with 
NPWT have not been the primary focus and that there is no study that includes a risk 
analysis of the impact of the wound etiology or patient-related factors. 
 
The limited research of the NPWT's impact on the patient's HRQoL points out a huge 
knowledge gap and more research are needed. To emphasize the impact the treatment 
has on the individual it is important to perform both qualitative and quantitative studies. 
To quantify data of HRQoL a validated disease-specific HRQoL instrument for patients 
with wounds treated with NPTW is required. 
 
The knowledge gained on treatment indications, risk factors and impact on the patient's 
HRQoL can lead to an individualized  wound treatment,  achieving  an effective  and 
gentle wound treatment that can decrease the suffering and increase the HRQoL of the 
patient. 
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4   AIMS OF THE THESIS 
 
 
The overall aim of this thesis was twofold: to study if NPWT is an effective and safe 
method for wound treatment, and to enhance the knowledge of the patient's experience 
of the treatment and the impact on the patient's HRQoL. 
 
 
Specific aims were: 
 
Study I         to describe basic demographic data, co-morbidity, treatment results, and 
complications  in  relation  to  wound  etiology  in  patients  treated  with 
NPWT. 
 
Study II        to   identify   wound-   and   patient-related   factors   associated   with   an 
increased risk of non-successful treatment and complications during 
treatment with NPWT. 
 
Study III       to describe the experience of patients with wounds treated with AMWT 
and NPWT. 
 
Study IV       to translate the wound-specific HRQoL-instrument CWIS and validate it 
for a Swedish population. 
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5  METHODS AND PARTICIPANTS 
 
 
In this thesis different  designs  and research  methods  have been used based on the 
research question of each study. An overview is presented in Table III. 
 
 
Table III. Overview of designs and methods 
 
Study     Design  Participants Data collection  Data analysis 
I Descriptive 
retrospective 
Consecutive series of 
patients treated with 
Chart review Fisher’s exact tests, Mann- 
Whitney U-test 
  study  NPWT (n=87)   
II Retrospective 
study 
Same as Study I Same as Study I Fisher’s exact tests, Chi- 
square test, Logistic 
  Risk analysis  regression   
III Qualitative 
descriptive 
study 
Patients treated with 
AMWT and NPWT 
having an acute wound 
Written diaries Qualitative content analysis 
  (n=15)   
IV Validation 
study 
Patients with acute and 
hard-to-heal wounds 
(n= 117) 
SF-36 and 
CWIS 
questionnaires 
Psychometric statistical 
analyses 
 
 
 
The NPWT system used to treat all patients included in this thesis was the vacuum- 
assisted  closure  (VAC)  device  (Kinetic  Concepts,  Inc.,  San  Antonio,  TX)  using 
regularly continuous subatmospheric pressure of 125 mm Hg. Dressings were changed 
two or three times a week. 
 
Hydrofibre  (Aquacele®)  with  transparent  film  dressing  attached  on  top  was  the 
dressing  used for creating  a moist  wound  environment  in the patients  treated  with 
AMWT in Study III. The dressing was changed three times a week. 
 
 
5.1 PARTICIPANTS 
 
5.1.1   Study I and Study II 
 
Studies  I and II were based on the same population. A consecutive series consisting of 
all patients who had been treated with NPWT during 2005-2007 at the hospital were 
included. Initially 92 patients were identified from hospital data charts. Three patients 
were excluded due to missing data and two patients had incomplete follow-up 
information, giving a final sample size of 87 patients. Demographic data are shown in 
Table IV. 
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 Female 34 (39) 
”59 \UV 25 (29) 
Age 60-74 yrs 32 (37) 
 •5 \UV 30 (34) 
 Postoperative wound 45 (52) 
 Peripheral vascular disease 11 (13) 
Etiology of wound Infection 9 (10) 
 Trauma 8 (9) 
 Pressure ulcer 14 (16) 
Existing Co-morbidity  63 (72) 
 
 
 
 
 
 
 
 
 
 
Table IV. Demographic data of Studies I and II 
Patient characteristics No (%) 
 
Male 53 (61) 
Gender 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.1.2   Study III 
 
From a large ongoing quantitative RCT all patients who completed their diaries were 
consecutively included in Study III. To be eligible for inclusion in the RCT, all 
participants had to have an acute wound (duration <six weeks), had to be cognitively 
adequate and able to speak and write the Swedish language. The included patients were 
between  41 and 91 years of age. All patients had wounds in the lower extremities 
(Table V). 
 
Table V. Demographic data of Study III 
AMWT n= 7 NPWT n=8 
 
Gender                   Male             4                                                6 
Female 3 2 
 
Age                                                  41-91                                         47-80 
 
Wound  diagnosis  - Postoperative complication 
- Trauma 
- Infection 
- Arterial insufficiency 
 
- Postoperative 
complication 
- Trauma 
- Venous insufficiency 
 
Data material Days 89 84 
Words/day    3-73 2-89 
 
 
The analysis  of the included  patients  was conducted  with diaries  written  by seven 
patients treated with AMWT and eight patients treated with NPWT. In contrast to 
quantitative research, where the sampling is preferably randomized, the most common 
sampling in qualitative research is purposive. The qualitative researcher aims at getting 
a sample that is rich enough to get an understanding of the phenomenon rather than to 
justify generalization  of the findings.  However,  since the aim of Study  III  was to 
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describe the experience of patients treated with two different wound treatment methods 
and to see if there were any differences between the patients' experience of the two 
methods, the ambition was to get the sampling as objective as possible. 
 
5.1.3   Study IV 
 
The patients in Study  IV were recruited from the orthopedic out- and inpatient clinics 
and wards, the dermatology and the podiatric/diabetic  clinic at the hospital. Initially 
149  patients  with  wounds  were  eligible  for  inclusion.  Thirty-two  patients  were 
excluded due to incomplete answers in the questionnaires, leaving a sample size of 117 
patients. The response rate for all patients at the one-week follow-up was 76% and at 
the six-week follow-up for the group with an acute wound 60% (Figure 3). The mean 
age of the population was 59 years (range 19-89) and 61% of the patients were male. 
 
 
 
Eligible for the study 
n=149 
 
 
Included in the study 
n=117 
Did not complete the 
questionnaires  n=32 
 
 
 
 
Lost to follow-up/ 
incomplete questionnaires 
n=12 
Acute wounds/ 
Orthopedic wounds 
n=58 
 
 
1 week follow-up 
 
Hard-to-heal  wounds 
n=59 
 
 
 
Lost to follow-up/ 
incomplete questionnaires 
n=11 
 
Acute wounds/ 
Orthopedic wounds 
n=46 (79%) 
 
 
6 week follow-up 
 
Orthopedic wounds 
n=12 
 
Diabetic Foot Ulcers 
n=28 
 
Lost to follow-up/incomplete questionnaires 
n=16 
 
1 week follow-up 
 
Venous leg ulcers 
n=19 
 
Acute wounds/ 
Orthopedic wounds 
n=35 (60%) 
 
Orthopedic wounds 
n=9 (75%) 
 
Diabetic Foot Ulcers 
n=18 (64%) 
 
Venous leg ulcers 
n=16 (84%) 
 
 
Figure  3. Flow-chart Study IV 
 
 
 
 
5.2   DATA COLLECTION 
 
5.2.1   Study I and Study II 
 
Studies  I and II are chart reviews of all medical records of the included patients. Data 
was entered into a study-specific predefined protocol. The protocol included basic 
demographic data, wound data, ASA-classification, co-morbidity and results from 
bacterial cultures taken during treatment. The etiology of the wounds was divided into 
five groups: 1) open postoperative wounds after either orthopedic or general surgery; 2) 
wounds related to peripheral vascular disease (PVD), including diabetic foot ulcers and 
arterial leg ulcers; 3) wounds due to primary infections, such as necrotizing fasciitis and 
erysipelas; 4) trauma-related wounds that could not be treated with primary closure; 5) 
pressure ulcers. In five cases, clarification  was done for classification  of the wound 
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etiology made by a general surgeon or an orthopedic surgeon. To calculate interrater 
reliability, a nurse not involved in the study reviewed a sample of the medical charts 
(n=9),  and  results  were  compared  to  those  of  the  chart  reviewer's,  with  an  84% 
agreement, which was regarded as excellent. 
 
Treatment outcome was abstracted verbatim from the medical records and classified as 
either: successful treatment (wound healed, wound bed improved and left for secondary 
intention as secondary granulation, secondary suture or skin graft) or: non-successful 
treatment (wound not improving or worsened or treatment discontinued due to 
complications). The motive for using this outcome measurement was to avoid non- 
adapted measurements for NPWT, such as complete healing and reduction of wound 
size and to achieve a more clinically useful assessment related to the purpose of the 
treatment. The duration of treatment was calculated from the recorded treatment start to 
the stop date. The follow-up time ranged from 24 to 48 months. 
 
All forms of adverse events and complications related to the treatment and documented 
in the patients'  medical  records  were  registered  and  categorized  as  wound  related, 
related  with  quality  of  life  issues  for  the  patient  or  related  to  problems  with  the 
technical equipment of the NPWT device. 
 
5.2.2   Study III 
 
Study III is a qualitative study using diaries as data collection method, to minimize the 
risk of recall bias as described by Gendrau, Hufford and Stone
59
. The patients were 
asked to write diaries every day during two weeks of treatment, or less if the wound 
treatment was terminated earlier for some reason. The patients were instructed to focus 
on  their  experience  of  the  treatment.  An  enrolled  team  of  nurses  reminded  the 
participant to write in the diary to enhance compliance according to Broderick et al
61
. 
 
The final material of the diaries written by the two treatment groups consisted of 173 
days of diary entries, ranging from two to 89 words each. The text was transferred into 
a computerized document to create a systematic overview of the entire material and to 
facilitate analysis. 
 
5.2.3   Study IV 
 
The CWIS instrument in Study IV was translated by a standardized method developed 
by MAPI Research Institute84. An example of the structure of the original CWIS is 
presented in Figure 4. The translated Swedish version underwent psychometric testing 
for reliability, validity and responsiveness. 
 
At  baseline,  the  patients  included  in the  validation  part  of Study  IV  filled  in the 
Swedish version of the CWIS and the SF-36. All patients received instructions to fill in 
the same two questionnaires after one week and then return them by mail. At the time 
of the one-week follow-up the patients received a text message or a telephone reminder. 
Patients with acute wounds were also followed up after six weeks by mail with a letter 
of instructions and a pre-paid postage envelope to send back the two questionnaires. 
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Figure  4. Items from the well-being domain of the original CWIS. With permission from the Cardiff 
University of Wales College of Medicine. 
 
 
5.3   DATA ANALYSIS 
 
5.3.1   Statistics 
 
The SPSS 17.0 and 20.0 (SPSS, Chicago, IL) was used for statistical calculations and 
analyses. Differences were considered significant if the two-tailed p-value was <0.05. 
 
In Study I Fisher's exact test was used for comparison of demographic variables due to 
small subgroups
85
. The distribution in age and treatment time was skewed, therefore 
presented as median values. The comparison in treatment time between patients with 
successful and non-successful NPWT treatment was calculated with the nonparametric 
Mann-Whitney U-test. 
 
In  Study  II  binary  logistic  regression  was  used  to study the associations  between 
different risk factors and two dependent variables: non-successful treatment and 
complications.  The  associations  were  presented  as  odds  ratios  (OR).  The  model 
strategy was to first study crude association with each risk factor in the univariable 
model, then adjusting the model for all the other variables resulting in a final model by 
excluding  all non-significant  variables.  The  Hosmer-Lemeshow  goodness-of-fit  test 
was used to examine if the final model sufficiently fit the data, with a p-value > 0.05 
showing an acceptable fit86. 
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5.3.2   Qualitative content analysis 
 
Qualitative content analysis was chosen as the best method for analysing the data in 
Study  III. Content analysis is a method for data analysis and was first described in the 
1950's. Initially it was predominately used in quantitative research but gradually it gets 
more often applied in qualitative research
87
. 
 
In Study  III  content analysis according to Graneheim and Lundman was performed 
and divided into seven steps
87
. The first six steps contained: 1) selecting the unit of 
analysis, in this study the diaries, 2) repeatedly reading the text to obtain a sense of the 
central message of the text and a deeper understanding of the content, 3) identifying 
meaning  units  which  is  the  constellation  of  words  that  relate  to  the  same  central 
meaning relevant to the research question and condensing the meaning units to get a 
better overview of the data, 5) the condensed meaning units were labeled with codes, 6) 
the codes were grouped into categories that reflected the central message of the text. 
This step was performed within the research team and discussions took place until 
consensus was reached. At this stage of the analysis, the researchers discussed their 
preconceptions developed through clinical experience of working with this group of 
patients for several years. Preconceptions can be seen as an asset and a great contributor 
to qualitative research when being recognized88. 
 
In the final seventh step, after the analysis had been made, the material was divided into 
two groups, patients treated with AMWT and patients treated with NPWT. Differences 
and  similarities  between  the  two  groups  were  analysed  and  discussed  within  the 
research  group.  In  this  material  the  codes  were  grouped  into  three  categories  that 
reflected the central message of the text from both groups, and the underlying meaning 
of the categories was formulated in one main theme. 
 
The analysis was performed initially with six diaries from patients treated with AMWT 
and  six  from  patients  treated  with  NPWT.  An  additional  three  diaries  were  then 
analysed (one from the AMWT-group and two from the NPWT-group), but no new 
information was obtained which led to a feeling of saturation. Saturation is a concept in 
qualitative research explaining the state when the collection of new data does not 
contribute to exploring the issue further and the amount of data analysed is considered 
to be sufficient89. 
 
5.3.3   Psychometric testing 
 
The Swedish version of the CWIS was evaluated for its psychometric properties by 
assessing reliability, validity, responsiveness and measures of ceiling- and floor-effects. 
 
Reliability was measured with internal consistency of the three domains of the CWIS at 
baseline, using Cronbach's alpha coefficient considered acceptable when 0.70 or higher. 
The test-retest stability was calculated with intraclass correlation based on patients with 
hard-to-heal  wounds  at baseline  and  at the one-week  follow-up,  using  0.60  as the 
lowest acceptable level90,91. 
 
Validity was estimated by using methods for face, content, discriminant and criterion 
validity.  Face and content  validity measures  the perceived  clinical  relevance  of the 
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questionnaire by intended users, and were assessed by wound patients and an expert 
group during the translation process. Discriminant validity is a measurement of the 
instrument's capacity to distinguish between different conditions and is calculated with 
mean difference of the two groups at baseline. Criterion validity compares scores of the 
instrument to another similar instrument regarded as gold standard. In Study IV the 
domains of the CWIS were compared to relevant domains of the SF-36 at baseline and 
correlations were calculated with Spearman's rho. 
 
Responsiveness estimates the ability of the instrument to detect clinically important 
changes. Standardized response mean (SRM) was used to evaluate internal 
responsiveness,  calculated  by dividing  the difference  between  baseline  and the six- 
week follow-up in patients with an acute wound, with the standard deviation of that 
difference. SRM was considered small (<0.5), moderate (0.5-0.8) or large (>0.8)
92
. 
 
Estimates of ceiling- and floor-effects were also performed since it is regarded as 
impossible to detect improvement or decline in health if over 15 percent of a group's 
scores are at the maximum or minimum possible score
93
. 
 
 
5.4   ETHICAL CONSIDERATIONS 
 
The ethical principle non-maleficence is embodied by the phrase, "first, do no harm," 
which states that it is more important not to harm your patient than to do him/her good. 
Of course this ethical principle is not absolute since many treatments will harm the 
patient, but the final outcome must be beneficial. There is a constant balance between 
the principle of beneficence (doing good) and the non-maleficence, defined as the 
principle of double effect. 
 
With the principle of non-maleficence as a base for the studies in this thesis, the focus 
of the objectives was to gain more knowledge, especially concerning risk factors for 
treatment  failure,  complications  and  negative  impact  of  NPWT  on  the  patients' 
HRQoL. By getting this further knowledge it is possible to balance the principle of 
double effect, i.e. the benefits of the treatment and the risks, so that, in the end, the 
patient will not be harmed. 
 
Ethical approval for collecting data from the medical records for the chart review in 
Studies I and II was obtained by the local Ethics Committee. 
 
In Studies III and IV the participants were given verbal and written information on the 
studies, and their consent was given. Ethical approval was obtained by the local Ethics 
Committee. 
 
All studies were performed in accordance with the Helsinki Declaration and with good 
clinical practice. 
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6  RESULTS 
 
 
6.1   TREATMENT EFFICIENCY 
 
In Studies  I and II, the primary outcome was if the treatment goals were achieved or 
not, and a success rate of 71 % (n=62) was noted. 
 
The present studies showed that the wound etiology had a significant impact on the 
treatment outcome (p=0.001). The highest rate of successful treatment was shown in 
patients with infectious wounds (100%), followed by post-operative wounds (82%). 
Patients with PVD had the lowest rate of successful treatment, with only three patients 
(27%) recorded as having had a successful outcome. The indication for treatment of the 
wound had an impact on the outcome. Wounds with the treatment goal of optimized 
wound healing, when all other treatment options had failed, had the lowest success rate 
(p=0.03). 
 
The importance of treatment time and treatment result for patients with different wound 
etiology treated with NPWT was assessed in Study I. There were no significant 
differences in the length of treatment between the successfully treated (median 17 days) 
and the non-successfully treated wounds (median 19 days). However, wounds with 
different etiology required different treatment time to achieve a successful result. For 
wounds caused by trauma the figures showed that wounds with a successful treatment 
outcome had a rather short treatment time. Wounds with non-successfully treatment 
outcome tended to have a longer treatment time, indicating that results of treatment 
should be noted early, otherwise there seems to be no advantage to keep on with the 
treatment.  On  the  contrary,  pressure  wounds  needed  a  longer  time  to  achieve  a 
successful result. 
 
Non-successful  treatment  results  were  noted  for  25  patients  (29%).  Risk  factors 
associated with an increased risk of treatment failure was presented in the univariable 
logistic regression analysis in Study  II:  atherosclerosis  in the lower extremities (OR 
5.4), diabetes (OR 3.2), having a wound due to PVD (OR 12.3) or a pressure ulcer (OR 
4.6),   and   positive   bacterial   culture   for   Staphylococcus   Aureus   (OR   3.4)   and 
Pseudomonas Aeruginosa (OR 4.4) in the wound. In the adjusted multivariable model 
only the risk factors of having a pressure ulcer (OR 6.2) and the presence of 
Staphylococcus Aureus (OR 4.7) remained statistically significant. The Hosmer- 
Lemeshow  goodness-of-fit  test indicated  adequately fit the data for the final model 
(0.28). 
 
 
6.2   TREATMENT SAFETY 
 
Studies  I and II  showed a complication rate of 21% (Figure 5). Wounds associated 
with  PVD  had  the  highest  frequency  of  complications  (64%).  Wounds  with  an 
infectious origin and wounds related to trauma had no complications registered during 
treatment. Complications related to the wound (n=10) were the most common adverse 
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event with infection being the most frequently occurring complication (n=5), followed 
by patient-perceived deterioration of the HRQoL (n=4). 
 
Unintended termination of treatment due to complications with NPWT was registered 
for 14 patients, mainly due to wound complications and because the patients perceived 
a deterioration of his/her HRQoL. 
 
 
 
 
Complications* 
n=18/87 (21%) 
 
 
Successful 
treatment result 
n=2 
Non successful 
treatment result 
n=16 
 
Wound infection 
(Post-op wound) 
Technical problem 
(Pressure ulcer) 
 
 
Terminated 
treatment 
n=14 
 
 
Continued 
treatment 
n=2 
 
 
Post-operative 
wound (n=5) 
 
Wound infection 
Worsened skin status 
Bleeding 
Decreased HRQoL 
 
Wound due to 
PVD (n=7) 
 
Wound infection 
Worsened skin status 
Bleeding 
Decreased HRQoL (n=2) 
 
Pressure ulcer 
(n=2) 
 
Wound infection 
Decreased HRQoL 
Worsened skin status 
(Post-op wound) 
Wound infection 
(Pressure ulcer) 
Suspicion bowel fistula Decreased general health status 
Technical problem 
 
 
Figure  5. Distribution of complications 
*Infectious wounds and wounds due to trauma had no complications registered. 
 
 
The  univariable   logistic  regression   analysis   performed   in  Study   II,   showed   a 
significant association of higher risk for complications in patients with atherosclerosis 
in the lower extremities (OR 4.4), wounds due to PVD (OR 9.5), positive culture of 
Staphylococcus Aureus (OR 5.3) or Pseudomonas Aeruginosa (OR 6.1). In the 
multivariable analysis statistical significance only remained for the presence of 
Staphylococcus  Aureus  (OR  14.3)  and  Pseudomonas  Aeruginosa  (OR  18.5).  The 
Hosmer-Lemeshow goodness-of-fit statistics was 0.87. 
 
Gender, age, ASA-score, ongoing dialysis, diabetes, smoking, current cardiovascular 
disease, alcohol abuse and other bacterial species registered in the cultures taken during 
treatment were variables tested as non-significant, as well as the other wound types not 
mentioned above. 
23  
 
 
 
 
 
 
6.3   IMPACT ON THE PATIENT'S HRQOL 
 
The results from Studies I and II  showed that treatment with NPWT could have a 
negative impact on the patient's  HRQoL. In four cases, which represent 22% of all 
documented complications, it was reported of patients' perceived deterioration in 
HRQoL. The impact on the patients was severe enough for the physician to terminate 
the treatment in all cases. 
 
Patients treated with NPWT and AMWT describe their experience of the treatment in 
Study Ill There were a lot of similarities but also descriptions unique for the different 
treatment modalities. The content analysis identified one main theme and three 
categories, which covered both groups (Figure 6). 
 
 
 
Threat to 
normality 
 
  I   
I I I 
 
Impact on daily 
Manageability Powerlessness 
life 
 
 
Figure 6. Theme and categories of Study III 
 
 
Having a wound and the necessity of having to undergo wound treatment had an impact 
on the patients and threatened their possibilities of being able to lead a normal life, 
regardless of treatment modality. 
 
Both patient groups described that the wound treatment affected their daily life. 
However, there were differences in how their lives were affected depending on the 
treatment modality. The group treated with AMWT mainly focused on pain during the 
treatment, which was not described at all by the group treated with NPWT. This is in 
line with the findings in Study II, only one patient related his/her deteriorated HRQoL 
to increased pain during treatment with NPWT. The main focus of patients treated with 
NPWT described in Study III was instead machine-associated. Particularly the optimal 
functioning  of  the  machine  and  problems  with  a  non-functioning  machine  was 
described as being major concerns to the patients treated with NPWT. In Study II the 
majority ofHRQoL-related complications were related to the NPWT device. 
 
The patients treated with AMWT and NPWT  had different ways of managing the 
impact the treatment had on their daily life. Patients treated with AMWT expressed a 
desire for external feedback and support from the health-care personnel to feel safe and 
cared for. Patients treated with NPWT needed the health-care personnel to facilitate the 
development of an internal confidence for the patient to feel safe in managing the 
treatment and the machine at home. 
 
When the patients did not have enough strength and resources to cope with the strains 
of the treatment, feelings of weakness and powerlessness arouse. Patients treated with 
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AMWT expressed this state as being tired; tired of the wound, the treatment, not being 
able to live their normal life, loss of their social role and a feeling of inadequacy. The 
patients treated with NPWT described helplessness,  the feeling of being abandoned 
with the machine  as the most stressful  feeling.  An explanation  could be that these 
patients were treated on an outpatient basis and had no back-up during afterhours when 
the clinic was closed, contributing to increased anxiety in case of mal-functioning of 
the machine. 
 
 
6.4   PSYCHOMETRIC PROPERTIES OF THE SWEDISH CWIS 
 
As shown in studies  I-III  the treatment with NPWT has an influence on the patients' 
HRQoL  generating  a need of a wound-specific  HRQoL  instrument  to quantify  the 
findings and bring the research in this matter further. The CWIS was translated and 
then validated in a Swedish context regarding reliability,  validity, responsiveness  in 
Study IV. 
 
Reliability of the CWIS calculated with Cronbach's alpha showed acceptable internal 
consistency of the three domains 'well-being', 'physical symptoms and daily living' and 
'social life' (0.69-0.92). All domains proved stable over time with measurement of test- 
retest stability with interclass correlation >0.60 (0.66-0.80). 
 
Face and content validity were judged as good by the assessment made by patients and 
the expert group. The instrument was seen as comprehensible and clinically relevant. 
The mean difference between acute and hard-to-heal wounds, in the assessment of 
discriminant validity, was statistically significant for the domains WB and SL. There 
were numeric differences in the domain PSDL. Criterion validity was calculated with 
correlation between the CWIS and relevant domains of the SF-36, reaching moderate to 
high values, and was comparable to a reference material
71 
. 
 
SRM, used for calculations of internal responsiveness, showed moderate to large values 
(0.62-1.12), indicating that the Swedish version of the CWIS has the ability to detect 
changes that are considered clinically important. 
 
There were no signs of either ceiling- or floor-effect, since none of the patients scored 
the lowest possible score and only seven percent reached the highest value, leaving a 
wide margin to the cut-of-point of 15 percent93. 
 
The measurement of the psychometric properties of the Swedish version of the CWIS 
in Study  IV showed that it is a reliable and valid tool for measuring the HRQoL in 
patients with acute and hard-to-heal wounds. 
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7  DISCUSSION 
 
 
7.1   GENERAL DISCUSSION 
 
This thesis shows that NPWT is an effective and safe treatment, and that the treatment 
results are influenced by the etiology of the wound. It also presents risk factors for a 
non-successful treatment result and for complications, which should be taken into 
consideration in the clinical setting. The thesis also presents the differences in focus, 
concerns and needs between patients treated with either AMTW or NPTW and that the 
need to further investigate the treatment's impact on the patients' HRQoL is met by the 
translation and validation of a Swedish wound-specific HRQoL instrument. 
 
NPWT has been defined as the greatest innovation and progress in modern wound 
management  and  the  treatment  results  seen  have  been  astounding.  Clinically,  the 
method has made it possible to perform advanced surgery with minimized morbidity 
and mortality in patients with severe and hard-to-heal wounds. It has also contributed to 
managing  HRQoL-issues,  particularly  in patients  with large dehiscent  wounds  as it 
gives a wound closure and the patient a “whole” body, creating a hope of recovery and 
health. However, despite experienced overwhelming success of the treatment there is a 
minority of patients  that do not benefit  from the treatment.  In every day work the 
health-care  personnel  are forced  to make  decisions  on treatment  options,  trying  to 
balance the effectiveness and results of the treatment with the wellbeing of the patient. 
The goal of this decision is that the cure should never be worse than the disease and 
always be beneficial to either the patient him/herself directly or indirectly to posterity. 
To facilitate treatment decisions, extended knowledge is needed to establish if NPWT 
is an effective and safe treatment method and the impact on the patient's HRQoL and 
experience of the treatment. The main objective of this thesis was to generate this 
knowledge. 
 
The success  rate of NPWT  presented  in Study  I  was 71%.  It was concluded  that 
treatment with NPWT is safe and effective. However, when turning the figures around, 
almost one third (29%) had a non-successful treatment result. The result caused great 
concern and demanded  a re-evaluation  of the true conclusion  of the efficiency  and 
safety of NPWT. The final statement is that NPWT is an effective and safe treatment 
for most patients, although not beneficial to all, even worse: it may even be harmful to 
some. This implies a demand for further research on risk factors for treatment failure 
and complications. 
 
The finding that wounds due to infectious origin had a 100% treatment success and no 
complications registered is a contradiction, as infection was the most common 
complication. This can eventually be explained by the bacterial cultures. Patients with 
wound   infection   as  a  complication   during   treatment   were  mostly  infected   by 
Pseudomonas Aeruginosa or Staphylococcus Aureus, both associated with a high risk 
of complications. For patients with a wound of infectious origin the cultures mainly 
consisted of anaerobe bacterial species not associated with complications in the risk 
analysis of Study  II. Another explanation could be a neglect to treat an infection that 
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occurs during NPWT, while wounds with an infectious origin were treated with wound 
revisions and NPTW as a complement to other interventions. 
 
The findings in Study  II show that patients with wounds due to PVD are a major risk 
group of having a non beneficial result and complications with NPWT. This result puts 
the statement in the review by Xie et al that there is existing evidence of beneficial use 
of NPWT in patients with diabetic foot ulcers even more in focus
40
.  As mentioned in 
the background of this thesis, the patients in the studies assessed in the review had 
sufficient arterial circulation. In Study II most patients with diabetes also had 
atherosclerosis, a very common combination. This leads to the assumption that the 
recommendation  should  rather  be  that  wounds  in  the  feet  can  be  treated  if  the 
circulation is sufficient, even if the patient has diabetes. 
 
Smoking has been described as a major wound healing inhibitor2. Somewhat surprising, 
smoking as a risk factor for non-successful treatment result and complications came out 
inconclusive in the risk analysis in Study II. An explanation of this could be that at the 
time of the data collection, smoking habits were not always reported in the patients' 
charts and missing information  was classified as the patient not having the habit or 
disease. It could lead to an underestimation and to affect the result. This demonstrates 
one of the disadvantages with retrospective studies and points out the necessity of 
prospective studies. 
 
The results of this thesis show that NPWT has an impact on the patients' HRQoL and 
that patients  undergoing  wound treatment  have different  focus, concerns  and needs 
related to treatment modality. The result from Study  III  shows, for the first time, the 
unique  experience  of  patients  treated  with  NPWT  and  how  it  differs  from  the 
experience of patients treated with so called conventional treatment with dressings. The 
knowledge of unique features of the experience of patients treated with different 
treatments is scarce and the existing research has so far only described the experience 
of the patients exclusively and not with compared to other treatments. This causes a 
knowledge gap of information required for individualization of the care. 
 
As Maya Angelo´s famous quote: 
 
“When you know better, you do better” (Maya Angelo) 
 
The result in Study III describes that the main focus for patients treated with NPWT is 
the machine and its optimal functioning. Handled in an optimal way this information 
can  enhance  the  possibilities  of  providing  high  quality  care  and  the  health  care 
personnel to “do better”. 
 
Studies I-III  all include parameters of what impact the NPWT treatment has on the 
patients' HRQoL. The results show that NPWT may affect the patients to a greater 
extent than previous research has proven. The strongest limitations in Studies  I and II 
are that the negative  impact of HRQoL is only shown as complications  in a small 
sample without control group. Nevertheless, these results have contributed to valuable 
information and have generated research questions for further investigations. The result 
of Study  III  together  with the previous  results  clearly demonstrates  the need of a 
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quantitative tool for measuring disease-specific HRQoL in wound patients, not only for 
research purposes but also as a tool for exploring the individual patient's suffering in a 
clinical  setting.  In searching  the literature  for an appropriate  instrument  to use, the 
CWIS  was  found.  One  of  the  major  advantages  with  the  CWIS,  apparent  when 
performing  the  validations  process  in Study  IV,  was  the  focus  on  symptoms  and 
problems during the treatment, giving an opportunity to use the instrument as a clinical 
tool to visualize, focus on and treat the problems, and by that a possibility to ease the 
suffering of the patients. 
 
In this thesis the outcome measurement chosen was if treatment goals were achieved or 
not. The reason for choosing this endpoint can be explained by previous research on 
NPWT.  EWMA  has presented  a list of 313 endpoints  in total for wound research, 
which  causes  difficulties  in  comparability  of  different  studies
56
.  In  several  large 
reviews, the conclusions are that there is no evidence of the effectiveness of NPWT and 
that  it  should  not  be  used  in  clinical  practice  until  more  solid  evidence  has  been 
presented: 
 
“There is no valid or reliable evidence that topical negative pressure 
increases chronic wound healing.”
76
 
 
“The authors  of the review believe that there is not sufficient scientific 
evidence to advise the use of NPWT over standard  treatment of chronic 
wounds.”
31
 
 
The main problem with these reports, and others, is that they use complete healing or 
reduced wound size as the primary endpoint, but as the main treatment goal for NPWT 
often is to facilitate healing and not to heal the wound, the endpoint should rather be if 
facilitated healing was achieved or not. This will also give the evaluation of treatment 
with NPWT a more accurate assessment and emphasize the importance of setting up 
treatment  goals  and  evaluate  them  in  reasonable  time.  As  shown  in  Study  II  the 
indication for treatment and treatment goal has a significant impact on the outcome, 
showing  excellent  results  for  wounds  not  mentioned  in  the  reviews,  for  example 
wounds with infectious etiology. 
 
It should also be emphasized that it is not only the endpoints that cause difficulties in 
comparison between studies but also the complexity of this group of patients. To be 
taken into account is that the patients are often old, fragile and suffer from several other 
diseases, and that other interventions such as pressure release and nutrition can have a 
major impact on the treatment outcome. Other problems are that the studies often are of 
inadequate sample size, have insufficient follow-up periods and are non-randomized 
and non-blinded.  However,  as mentioned  before,  performing  high level research  of 
high  quality can be both difficult  and time  consuming,  which  has been  shown  by 
several randomized studies that has been terminated due to problems of recruiting 
patients94. Evidence-based practice consists not only of research but also of proven 
experience, Vig et al and Kaplan have presented clinical recommendations by using 
consensus in form of consultations of experts using the treatment
17,22
. It is not ethical to 
treat patients with treatments unknown of their effectiveness and impact on the patients, 
nor is it ethical to refrain from using an effective method simply due to insufficient high 
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quality research if the clinical experience shows that the patients clearly benefits from 
the treatment. 
 
 
7.2   METHODOLOGICAL CONSIDERATIONS 
 
To minimize selection bias a consecutive series of patients was included in Studies  I 
and II. Including the entire accessible population over a long enough period of time 
enhances the validity of the study
95
. In Studies I and II, all patients treated with NPWT 
during a three year period were included. However, not having a control group makes 
that the results can only be interpreted as descriptive generating new research questions 
and hypotheses. 
 
There are several methodological concerns when using chart review as data collection 
method. Gilbert, Lowenstein,  Koziol-McLain,  Barta and Steiner point out that even 
though medical charts contain important clinical information they are not produced for 
research purposes and information taken from medical records is often unreliable. Their 
study on quality of data in emergency medicine chart reviews revealed a lot of errors, 
inconsistencies   and  omissions  due  to  errors  and  idiosyncrasies   in  the  reading, 
interpreting, coding, and transcribing of data96. Panacek has shown that even with the 
disadvantages and limitations of chart review there are ways of improving validity by 
following his quality checklist “The 10 Commandments for Performing Chart Review 
Research”.  The  ten  steps  consist  of  issues  with  abstract  forms,  training  of  the 
abstractors, monitoring, blinding and testing inter-rater agreement
97
. The chart review 
process of Studies  I and II included all but one of the recommended steps, blinding 
was not achieved. Both Panacek
97  
and Gilbert et al
96  
emphasize the importance of the 
interrater  reliability test, and in Studies  I  and II  a second reviewer re-abstracted  a 
sample of the charts and achieved an 84% agreement between raters which may be 
considered an adequate interrater reliability score. Even though all efforts to enhance 
validity and reliability, research based on chart reviews must be carefully examined and 
conclusions must always be of a tentative nature, due to the possibility of errors or 
omissions in charting. 
 
In traditional quantitative research the concepts of validity and reliability are used to 
describe the trustworthiness and quality of the research results. These concepts are also 
often used in qualitative research, but other concepts exist that are more suitable for the 
qualitative research paradigm. Graneheim and Lundman suggest application of these 
specific   concepts:   credibility,   dependability   and  transferability87,   which  will  be 
discussed in connection with Study III: 
 
Credibility 
The concept credibility deals with how well data and analysis are performed in 
concordance with the aim of the study. Primarily the concern is regarding the focus of 
the study, selection of context, participants and data collection
87
. To minimize the recall 
bias in data collection concerning inadequacy in memory amongst the participants, a 
day to day diary was chosen. This choice of data collection method was criticized at the 
planning phase of Study III, predicting that the quantity of data received would be 
insufficient. However, during the data analysis, a sense of saturation of the material was 
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achieved, showing a satisfactory amount of data. One strength of the study is that it is 
likely that the material  written  in the diaries  was the most important  issues to the 
patients, giving a strong and relevant content to analyse. Another issue concerning 
credibility is how well categories  and themes cover data. Graneheim  and Lundman 
mean that seeking agreement among others, for example co-researchers, experts and 
participants and using representative quotations is a way of approaching this problem
87
. 
The whole process of analysis in Study III was performed in close collaboration in the 
research group until consensus about the findings was reached. The results were also 
discussed and analysed among co-workers and wound experts to achieve clinical 
credibility. 
 
Dependability 
The concept means the possibility to reproduce the research. Dependability deals with 
to what degree data and context change over time. The researcher is responsible for 
describing the changes that occur in the setting and how these changes affect the way in 
which the researcher approached the study87. In Study  III  data were collected during 
one  year.  There  were no major  changes  in the structure  of the wound  care  given, 
regarding new treatment methods or dressings. The health-care personnel performing 
dressing changes were stable during the inclusion period, giving a satisfactory 
dependability of the results shown in Study III. 
 
Transferability 
This concept contains issues to what extent the findings can be transferred to another 
group or setting. According to Graneheim and Lundman, the researcher can only give 
suggestions about transferability, in the end it is always the reader's decision if it is 
feasible87. To make it easier for the reader to manage this decision, it is valuable to give 
a good description of the context, participants and the process of data collection and 
data  analysis.  An  attempt  to  deal  with  this  challenge  was  made  by  focusing  on 
establishing an exact and precise description of the research process in the manuscript 
of Study III. Regarding transferability of the results in Study III it should only be seen 
as   awareness-raising   knowledge   on   wound   patients   and   not   as   representative 
experience of everyone treated with NPWT and AMWT. 
 
In Study IV, the translation and validation process was conducted along established 
systematic methods, thoroughly assessing the psychometric properties of the Swedish 
version of the CWIS. Test validity concerns the measurement instrument and refers to 
the degree to which evidence and theory support the interpretations of test scores. The 
assessment is strengthened by using both the original validation study of the instrument 
and one study similar to Study IV as reference material71,72. 
 
The number of incompletely filled-in questionnaires at baseline and at follow-up may 
be considered as a limitation of Study  IV. However, the sample size in this study is 
similar   or  considerably   larger   than   in  other   validation   studies   of  the  CWIS- 
instrument
71,72
, indicating a sufficient sample size to asses and achieve test validity, as 
also shown by the figures. Still, a plausible explanation could be that the questionnaire 
was too extensive and the design where the patient assesses both the experience and the 
stress of symptoms confusing. 
30  
 
 
 
 
 
 
 
7.3   IMPLICATIONS FOR CLINICAL PRACTICE 
 
The results of the studies in this thesis have pointed out the importance of setting up 
clinically relevant goals for treatment with NPWT and to take risk factors into 
consideration  before  treatment  start.  The  etiology  of the  wound  has  an  impact  on 
treatment outcome, and it is important to be aware of expected result when evaluating 
the treatment after two weeks as recommended by the manufacturers. Treatment time 
has also been shown to be of relevance when evaluating the treatment, for example 
pressure ulcers may have little or no progress after two weeks' treatment, while wounds 
due to trauma ought to have rapid treatment effect otherwise the treatment modality 
may not be optimal. Development  of treatment algorithms  based on etiology of the 
wound and risk factors for a non-successful treatment result and complications with 
scheduled   evaluations   could   be   an   effective   and   safe   way   of   working   with 
implementation of the treatment in clinical use. 
 
The results in Study  II concerning bacterial culture indicate that NPWT must be seen 
not as a wound-cleansing method, but highlights proper debridement, wound revisions 
and antibiotics to enhance the possibility of a successful treatment. The results also 
point out the necessity of evaluating and treat an insufficient peripheral circulation. 
 
The findings presented in this thesis regarding the impact on the patient's HRQoL and 
how the patients experience NPWT show that these patients have a machine-related 
focus. This must be taken into account when preparing the patient for treatment. This 
could be achieved by adjusting the information and patient education provided, making 
the patient feels more secure. One key issue regarding the patient's feelings of 
manageability was to know where to turn to, to get help and support if necessary. An 
organizational suggestion would be that one of the inpatients wards of the department 
would  be  responsible  for  the  patients'  care  and  treatment  after  office  hours  or  to 
organize a system of personnel on call. 
 
The validated Swedish version of the CWIS could be used not solely in research but 
also as a clinical tool for screening assessments when meeting a wound patient for the 
first time. This gives a good overview of possible problems and symptoms that could 
be addressed and treated or eased. This could help the patients to communicate issues 
relevant to them and contribute to an individualized care adjusted to the patients based 
on particular problems and concerns, not only focusing on the wound but the entire 
human being. 
 
 
7.4   FUTURE RESEARCH 
 
The research questions  generated  by the results in Studies  I and II  concerning  for 
example smoking as a risk factor and the impact the patient's peripheral circulation in 
the lower extremities  has on treatment outcome, together with the discussion of the 
result of bacterial cultures, is currently handled in the ongoing RCT mentioned earlier. 
In that study a sample size of 200 patients is randomized between AMWT and NPWT, 
focusing on variables that the findings in Studies  I and II indicated being of interest. 
The primary outcome chosen in the RCT is whether the treatment goal is achieved or 
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not, motivated by the criticism of outcome measurements raised in the literature and in 
this thesis. 
 
Studies I and II show that NPWT has an impact on the patient's HRQoL and Study III 
shows that patients treated with different methods have different needs and concerns. 
The previously published literature neither rejects nor confirms these differences. Since 
there is only one study, by Ousey et al, assessing  HRQoL in patients  treated  with 
NPWT compared to AMWT, and as that study only consists of 21 patients
81
, there is a 
demand for larger quantitative studies of sufficient power. By the translation and 
validation  in Study  IV  of the CWIS,  it is possible  to use the instrument  with the 
objective to enhance knowledge of the differences and in what areas the differences are, 
which is important when individualizing the wound treatment. 
 
Throughout  the validation  process in Study  IV,  the participating  patients expressed 
certain concern regarding the extent of the CWIS, and a modified less extensive version 
of the CWIS is desirable. This could also contribute to an easier way to use the 
questionnaire in the clinical work. An experimental pre-psychometric testing of a 
shortened version of the CWIS gives promising results, similar to the results of the 
original version, thus needing a proper psychometric evaluation. 
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8  CONCLUSIONS 
 
 
x    NPWT  is  an  effective  and  safe  treatment  method  with  outcome  results 
depending on the etiology of the wound. 
 
x    The risk factors identified for a non-successful result pinpoints the necessity of 
taking steps to ensure meticulous control of infection and insufficient peripheral 
circulation. 
 
x    Patients with insufficient peripheral circulation in the extremities have a risk of 
both unsuccessful treatment and complications. 
 
x    Wound treatment has an impact on the patients´ HRQoL. Patients have different 
focus, concerns and need related to treatment modality. 
 
x    Patients treated with NPWT are focusing mainly on the machine and its optimal 
functioning creating a need of internal confidence in managing the treatment 
and the machine at home on their own. 
 
x    The Swedish version of the CWIS has been proven to be a reliable and valid 
instrument for measurement of wound specific HRQoL. 
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9  SAMMANFATTNING (SUMMARY IN SWEDISH) 
 
 
Bakgrund 
Sår har genom historien varit orsaken till ett stort lidande för den drabbade och en stor 
belastning för samhället. Svårläkta sår har ofta orsakat problem där den traditionella 
sårbehandlingen har sviktat. På grund av detta har komplementära metoder utvecklats. 
En  av  dessa  komplementära  metoder  är  sårbehandling  med  undertryck,  Negative 
Pressure Wound Therapy (NPWT). 
 
Syfte 
Det  övergripande  syftet  med  avhandlingen  var  att  undersöka  om  behandling  med 
NPWT  är  effektiv  och  säker  samt  hur  behandlingen  påverkar  patienternas 
hälsorelaterade livskvalitet. 
 
Studie I och II 
Dessa studier är retrospektiva deskriptiva studier med syfte att beskriva grundläggande 
demografiska data, komorbiditet, behandlingsresultat och komplikationer utifrån sårets 
etiologi hos patienter behandlade med NPWT samt att identifiera riskfaktorer relaterade 
till ett misslyckat behandlingsresultat  och komplikationer med NPWT. Journaler från 
en konsekutiv serie av 87 patienter, (median 68 år, 16-92 år), behandlade med NPWT 
under en treårsperiod granskades. Framgångsrik behandling noterades för totalt 62 
patienter (71%) med en behandlingstid av 17 dagar. Behandlingskomplikationer 
observerades hos 18 patienter (21%). De starkaste riskfaktorerna associerade med ett 
misslyckat  behandlingsresultat  var  trycksår  eller  positiv  odling  för  Staphylococcus 
Aureus.  Ett  positivt  odlingssvar  för  antingen  Staphylococcus  Aureus  eller 
Pseudomonas aeruginosa var starkt associerad med risk för komplikationer under 
behandlingen. Patienter med nedsatt perifer cirkulation i extremiteterna hade en ökad 
risk för både misslyckat behandlingsresultat och komplikationer. 
 
Studie III 
Denna kvalitativa studie hade som syfte till att beskriva upplevelsen hos patienter med 
sår  som  behandlades  med  avancerad  fuktighetsbevarande   förband  (AMWT)  eller 
NPWT. Data samlades in från 15 dagböcker skrivna av patienterna under behandlingen 
och analyserades  med innehållsanalys.  Resultatet identifierade  ett övergripande  tema 
hot mot normalitet, och tre kategorier påverkan på dagligt liv, hanterbarhet och 
maktlöshet.  Det  fanns  många  likheter  i  beskrivningarna  men  också  olikheter.  För 
patienter som behandlats med AMWT var den viktigaste frågan smärta; för patienter 
som behandlas med NPWT var det istället optimal funktion av NPWT-maskinen. 
 
Studie IV 
Denna studie hade som syfte att översätta och validera det sårspecifika hälsorelaterade 
livskvalitetsinstrumentet  Cardiff  Wound  Impact  Schedule  (CWIS)  för  att  möta  de 
behov som identifierats i de tre första studierna. Totalt 117 patienter med akuta och 
svårläkta sår inkluderades. Tester avseende reliabilitet, validitet, responsivitet samt tak- 
och golveffekter visade att CWIS är ett pålitligt och trovärdigt verktyg för att mäta 
hälsorelaterad livskvalitet. 
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Slutsatser 
NPWT kan vara en effektiv behandlingsmetod men resultatet är beroende av sårets 
etiologi. Det är ingen riskfri behandlingsmetod  utan misslyckade behandlingsresultat 
och allvarliga komplikationer förekommer. Otillräcklig blodcirkulation i benen är en 
riskfaktor vid behandling med NPWT. Sårbehandling har en inverkan på patienternas 
hälsorelaterade livskvalitet och patienter som genomgår sårbehandling har olika fokus, 
problem och behov beroende på behandlingsmetod. Det finns ett behov av ytterligare 
forskning om effektiviteten av behandlingen och vilken påverkan den har på patientens 
hälsorelaterade livskvalitet. Den svenska versionen av CWIS behöver utvärderas som 
ett kliniskt verktyg vid vården av patienter med sår. 
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